An observational study in Periodontal Diseases and Dental Implant Failed, sponsored by University of Guarulhos. Enrolling by invitation at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-17.
Sponsored by University of Guarulhos · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 64 studies in Periodontal Diseases with a site in Brazil — 5 open to participants now, 7 under way, 1 of them phase 3. Periodontal Diseases · Brazil.
Among the 64 studies in Periodontal Diseases with a site in Brazil, this one is one of 4 that started in 2026, is one of 8 observational ones, and was the 61st registered.
871 studies on the registry are indexed under Periodontal Diseases; 191 are open to participants now.
Browse Periodontal Diseases studies →5 of the 64 studies in Periodontal Diseases with a site in Brazil are open now. Recruiting first, the newest first:
Universidade Federal Fluminense · Sites in Brazil
Ages 18–70 · Healthy volunteers
University of Campinas, Brazil · Sites in Brazil
Ages 18+
Colgate Palmolive · Sites in Brazil
Ages 30–70
University of Guarulhos · Sites in Brazil
Ages 18+ · Healthy volunteers
A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →
Of the 102 Periodontal Diseases studies recruiting now, 48 (47%) set no upper age limit and 42 (41%) stop at 75 or younger; 5 take children under 18; 59 take healthy volunteers.
This study: 18 Years and older · all sexes.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
64 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 4 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is close to the median of 100 across 304 observational studies indexed under Periodontal Diseases.
Median enrollment 43 across the 56 interventional studies, 64 across the 8 observational. Of the 43 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 64 have an industry lead sponsor. The 10 most frequent:
University of Guarulhos is the lead sponsor of 17 studies on the registry; 4 are open to participants now.
University of Guarulhos has 8 studies filed under Periodontal Diseases — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 64 studies in Periodontal Diseases with a site in Brazil, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Implant-supported rehabilitation of regions with severe bone resorption is a challenge for implant dentists. Structures such as the maxillary sinus and the inferior alveolar canal often make it impossible to use implants of lengths considered standard in the literature. The use of short implants produced by additive manufacturing (AM) provides a new surface, promoting osseointegration and reducing problems such as peri-implantitis. However, longitudinal evaluations of implants produced by AM are still scarce in the literature. A total of 100 subjects rehabilitated with short implants produced by MA, with diameters between 4.0 to 6.0 mm and 5 to 7 mm in length, will be evaluated. Peri-implant bone remodeling, as well as clinical parameters, will be evaluated by implant and throughout the evaluation time. Periapical radiographs will be obtained and scanned, analyzed by software, and compared to baseline data. The data obtained will be analyzed, allowing longitudinal evaluations and the success rate of implant restorations supported by short implants.
Individuals (> 21 years old), of both sexes, specifically rehabilitated with Morse connection implants (Plenum Bioengenharia, Jundiai, SP, Brazil) in the posterior region of the jaws for implant-supported restorations, will be included in this study. Subjects will need to have at least baseline radiographic controls (immediately after implant placement) and radiographic controls at 12 and 36 months after implant placement. Individuals will be included in the population sample based on the following criteria: location, region of implant installation, implant diameter, and adaptation.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The aim of the study will be to evaluate the bone loss and peri-implant complications of short implants produced by additive manufacturing
The primary outcome variable of the study will be variation in bone remodeling between the initial and final values (measured in mm)
Bone loss measured from the abutment-implant junction to the first visible bone to implant contact visible in a X-ray
Time frame: 36 months
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jun 2026.
Of 79 non-industry observational studies under Periodontal Diseases, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 0 months is below that.
Counting every sponsor, half of 83 studies reached it within 13 months; a quarter within 7 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Guarulhos